IP Library Granted Patent US 7,485,662
Granted Patent B2
US 7,485,662 · App. 10/549,155 · Granted Feb 3, 2009

Therapeutic agent for diabetes mellitus

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,485,662
App. No.
10/549,155
Granted
Feb 3, 2009
Kind
B2
Abstract

An object of the present invention is to provide a therapeutic agent for diabetes mellitus or insulin resistance improving agent, or to provide foods and drinks, food and drink additives, and feeds or feed additives for treating diabetes mellitus or improving insulin diabetes. In order to achieve such an object, the present invention provides a therapeutic agent for diabetes mellitus and insulin resistance improving agent comprising hydroxyproline, a hydroxyproline derivative or a pharmaceutically acceptable salt thereof or foods and drinks, food and drink additives, feeds or feed additives for treatment of diabetes mellitus or improvement of insulin resistance comprising the same.

Claims (1)

1. A method for improving insulin resistance comprising administering, to a patient in need thereof, an effective amount of N-acetylhydroxyproline or N,O-diacetylhydroxyproline oleyl ester.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2009
From: KYOWA HAKKO KOGYO CO., LTD.
To: KYOWA HAKKO BIO CO., LTD.
Reel/Frame 022578/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2005
From: KAMIYA, TOSHIKAZU; SHIRAI, AKIO; TAKADA, MIHO; OGINO, FUMIKO
To: KYOWA HAKKO KOGYO CO., LTD.
Reel/Frame 017741/0409 →